AbbVie (Mexico) Chance of Future Stock Price Finishing Over 3,511
| ABBV Stock | MXN 3,472 57.50 1.61% |
AbbVie |
AbbVie Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of AbbVie for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for AbbVie Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| AbbVie Inc generated a negative expected return over the last 90 days | |
| AbbVie Inc has accumulated 64.19 B in total debt with debt to equity ratio (D/E) of 6.52, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AbbVie Inc has a current ratio of 0.89, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist AbbVie until it has trouble settling it off, either with new capital or with free cash flow. So, AbbVie's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like AbbVie Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for AbbVie to invest in growth at high rates of return. When we think about AbbVie's use of debt, we should always consider it together with cash and equity. | |
| About 71.0% of AbbVie shares are held by institutions such as insurance companies |
AbbVie Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of AbbVie Stock often depends not only on the future outlook of the current and potential AbbVie's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AbbVie's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.8 B |
AbbVie Technical Analysis
AbbVie's future price can be derived by breaking down and analyzing its technical indicators over time. AbbVie Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of AbbVie Inc. In general, you should focus on analyzing AbbVie Stock price patterns and their correlations with different microeconomic environments and drivers.
AbbVie Predictive Forecast Models
AbbVie's time-series forecasting models is one of many AbbVie's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary AbbVie's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about AbbVie Inc
Checking the ongoing alerts about AbbVie for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for AbbVie Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| AbbVie Inc generated a negative expected return over the last 90 days | |
| AbbVie Inc has accumulated 64.19 B in total debt with debt to equity ratio (D/E) of 6.52, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AbbVie Inc has a current ratio of 0.89, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist AbbVie until it has trouble settling it off, either with new capital or with free cash flow. So, AbbVie's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like AbbVie Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for AbbVie to invest in growth at high rates of return. When we think about AbbVie's use of debt, we should always consider it together with cash and equity. | |
| About 71.0% of AbbVie shares are held by institutions such as insurance companies |
Additional Tools for AbbVie Stock Analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.